Development and characterization of a chronic implant mouse model for vagus nerve stimulation

  1. Ibrahim T Mughrabi
  2. Jordan Hickman
  3. Naveen Jayaprakash
  4. Dane Thompson
  5. Umair Ahmed
  6. Eleni S Papadoyannis
  7. Yao-Chuan Chang
  8. Adam Abbas
  9. Timir Datta-Chaudhuri
  10. Eric H Chang
  11. Theodoros P Zanos
  12. Sunhee C Lee
  13. Robert C Froemke
  14. Kevin J Tracey
  15. Cristin Welle  Is a corresponding author
  16. Yousef Al-Abed
  17. Stavros Zanos  Is a corresponding author
  1. The Feinstein Institutes for Medical Research, United States
  2. University of Colorado Anschutz Medical Campus, United States
  3. New York University School of Medicine, United States

Abstract

Vagus nerve stimulation (VNS) suppresses inflammation and autoimmune diseases in preclinical and clinical studies. The underlying molecular, neurological, and anatomical mechanisms have been well characterized using acute electrophysiological stimulation of the vagus. However, there are several unanswered mechanistic questions about the effects of chronic VNS, which require solving numerous technical challenges for a long-term interface with the vagus in mice. Here, we describe a scalable model for long-term VNS in mice developed and validated in 4 research laboratories. We observed significant heart rate responses for at least 4 weeks in 60-90% of animals. Device implantation did not impair vagus-mediated reflexes. VNS using this implant significantly suppressed TNF levels in endotoxemia. Histological examination of implanted nerves revealed fibrotic encapsulation without axonal pathology. This model may be useful to study the physiology of the vagus and provides a tool to systematically investigate long-term VNS as therapy for chronic diseases modeled in mice.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 2, 3, and 4.

Article and author information

Author details

  1. Ibrahim T Mughrabi

    Institute of Bioelectronic Medicine, The Feinstein Institutes for Medical Research, Manhasset, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8057-6146
  2. Jordan Hickman

    Physiology and Biophysics, University of Colorado Anschutz Medical Campus, Aurora, CO, United States
    Competing interests
    No competing interests declared.
  3. Naveen Jayaprakash

    Institute of Bioelectronic Medicine, The Feinstein Institutes for Medical Research, Manhasset, United States
    Competing interests
    No competing interests declared.
  4. Dane Thompson

    Institute of Bioelectronic Medicine, The Feinstein Institutes for Medical Research, Manhasset, United States
    Competing interests
    No competing interests declared.
  5. Umair Ahmed

    Institute of Bioelectronic Medicine, The Feinstein Institutes for Medical Research, Manhasset, United States
    Competing interests
    No competing interests declared.
  6. Eleni S Papadoyannis

    Neuroscience, New York University School of Medicine, Manhattan, United States
    Competing interests
    No competing interests declared.
  7. Yao-Chuan Chang

    Institute of Bioelectronic Medicine, The Feinstein Institutes for Medical Research, Manhasset, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0340-4652
  8. Adam Abbas

    Institute of Bioelectronic Medicine, The Feinstein Institutes for Medical Research, Manhasset, United States
    Competing interests
    No competing interests declared.
  9. Timir Datta-Chaudhuri

    Institute of Bioelectronic Medicine, The Feinstein Institutes for Medical Research, Manhasset, United States
    Competing interests
    No competing interests declared.
  10. Eric H Chang

    Institute of Bioelectronic Medicine, The Feinstein Institutes for Medical Research, Manhasset, United States
    Competing interests
    No competing interests declared.
  11. Theodoros P Zanos

    Institute of Bioelectronic Medicine, The Feinstein Institutes for Medical Research, Manhasset, United States
    Competing interests
    No competing interests declared.
  12. Sunhee C Lee

    Institute of Molecular Medicine, The Feinstein Institutes for Medical Research, Manhasset, United States
    Competing interests
    No competing interests declared.
  13. Robert C Froemke

    New York University School of Medicine, New York, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1230-6811
  14. Kevin J Tracey

    Labolatory of Biomedical Science, The Feinstein Institutes for Medical Research, Manhasset, United States
    Competing interests
    Kevin J Tracey, K.J.T. holds patents broadly related to this work. He has assigned all rights to the Feinstein Institutes for Medical Research..
  15. Cristin Welle

    Neurosurgery and Physiology & Biophysics, University of Colorado Anschutz Medical Campus, Aurora, CO, United States
    For correspondence
    cristin.welle@cuanschutz.edu
    Competing interests
    No competing interests declared.
  16. Yousef Al-Abed

    Center for Molecular Innovation, The Feinstein Institutes for Medical Research, Manhasset, United States
    Competing interests
    No competing interests declared.
  17. Stavros Zanos

    Institute of Bioelectronic Medicine, The Feinstein Institutes for Medical Research, Manhasset, United States
    For correspondence
    szanos@northwell.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3967-8164

Funding

Defense Advanced Research Projects Agency (HR0011-17-2-0025)

  • Stavros Zanos

United Therapeutics Corporation

  • Stavros Zanos

Boston Scientific Corporation

  • Yousef Al-Abed

Defense Advanced Research Projects Agency (HR0011-17-2-0051)

  • Cristin Welle

Defense Advanced Research Projects Agency (N66001-17-2-4010)

  • Robert C Froemke

Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD088411)

  • Robert C Froemke

Brain Research through Advancing Innovative Neurotechnologies (NS107616)

  • Robert C Froemke

National Institute on Deafness and Other Communication Disorders (DC12557)

  • Robert C Froemke

Howard Hughes Medical Institute (Faculty Scholarship)

  • Robert C Froemke

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal experiments complied with relevant ethical guidelines and were approved by the Institutional Animal Care and Use Committee (IACUC) of the Feinstein Institutes for Medical Research (protocol numbers: 2016-029, 2017-010, and 2019-010) and University of Colorado Anschutz Medical Campus (protocol number: 00238).

Reviewing Editor

  1. Isaac M Chiu, Harvard Medical School, United States

Publication history

  1. Received: July 20, 2020
  2. Accepted: April 2, 2021
  3. Accepted Manuscript published: April 6, 2021 (version 1)
  4. Version of Record published: April 16, 2021 (version 2)

Copyright

© 2021, Mughrabi et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,985
    Page views
  • 520
    Downloads
  • 15
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ibrahim T Mughrabi
  2. Jordan Hickman
  3. Naveen Jayaprakash
  4. Dane Thompson
  5. Umair Ahmed
  6. Eleni S Papadoyannis
  7. Yao-Chuan Chang
  8. Adam Abbas
  9. Timir Datta-Chaudhuri
  10. Eric H Chang
  11. Theodoros P Zanos
  12. Sunhee C Lee
  13. Robert C Froemke
  14. Kevin J Tracey
  15. Cristin Welle
  16. Yousef Al-Abed
  17. Stavros Zanos
(2021)
Development and characterization of a chronic implant mouse model for vagus nerve stimulation
eLife 10:e61270.
https://doi.org/10.7554/eLife.61270

Further reading

    1. Immunology and Inflammation
    Yu Li, Pablo Guaman Tipan ... Lauren IR Ehrlich
    Research Article

    Central tolerance ensures autoreactive T cells are eliminated or diverted to the regulatory T cell lineage, thus preventing autoimmunity. To undergo central tolerance, thymocytes must enter the medulla to test their TCRs for autoreactivity against the diverse self-antigens displayed by antigen presenting cells (APCs). While CCR7 is known to promote thymocyte medullary entry and negative selection, our previous studies implicate CCR4 in these processes, raising the question of whether CCR4 and CCR7 play distinct or redundant roles in central tolerance. Here, synchronized positive selection assays, 2-photon timelapse microscopy, and quantification of TCR-signaled apoptotic thymocytes, demonstrate that CCR4 and CCR7 promote medullary accumulation and central tolerance of distinct post-positive selection thymocyte subsets in mice. CCR4 is upregulated within hours of positive selection signaling and promotes medullary entry and clonal deletion of immature post-positive selection thymocytes. In contrast, CCR7 is expressed several days later and is required for medullary localization and negative selection of mature thymocytes. In addition, CCR4 and CCR7 differentially enforce self-tolerance, with CCR4 enforcing tolerance to self-antigens presented by activated APCs, which express CCR4 ligands. Our findings show that CCR7 expression is not synonymous with medullary localization and support a revised model of central tolerance in which CCR4 and CCR7 promote early and late stages of negative selection, respectively, via interactions with distinct APC subsets.

    1. Biochemistry and Chemical Biology
    2. Immunology and Inflammation
    Minato Hirano, Gaddiel Galarza-Muñoz ... Mariano A Garcia-Blanco
    Research Article

    Genes associated with increased susceptibility to multiple sclerosis (MS) have been identified, but their functions are incompletely understood. One of these genes codes for the RNA helicase DExD/H-Box Polypeptide 39B (DDX39B), which shows genetic and functional epistasis with interleukin-7 receptor-α gene (IL7R) in MS-risk. Based on evolutionary and functional arguments, we postulated that DDX39B enhances immune tolerance thereby decreasing MS risk. Consistent with such a role we show that DDX39B controls the expression of many MS susceptibility genes and important immune-related genes. Among these we identified Forkhead Box P3 (FOXP3), which codes for the master transcriptional factor in CD4+/CD25+ T regulatory cells. DDX39B knockdown led to loss of immune-regulatory and gain of immune-effector expression signatures. Splicing of FOXP3 introns, which belong to a previously unrecognized type of introns with C-rich polypyrimidine tracts, was exquisitely sensitive to DDX39B levels. Given the importance of FOXP3 in autoimmunity, this work cements DDX39B as an important guardian of immune tolerance.